Here, we found that gilteritinib treatment inhibited the expression of ABCG1 in lung cancer cells, and the low expression of ABCG1 was similarly associated with poor survival in lung cancer patient, suggesting that the functions of ABCG1 in gilteritinib-mediated effects may be similar to those of ABCA1. Here, ABCG1 is linked to lung cancer.